Carotid intima-media thickness and cognitive decline: What does it mean for prevention of dementia?

Journal of the Neurological Sciences

Volumn 223, Issue 2, 2004, Pages 103-105

  Spence, J David ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LOSARTAN; VALSARTAN;

ATHEROSCLEROSIS; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; COGNITIVE DEFECT; DEMENTIA; DIABETES MELLITUS; DISEASE PREDISPOSITION; EDITORIAL; HEART INFARCTION; HUMAN; HYPERTENSION; INTIMA; MIXED DEPRESSION AND DEMENTIA; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; STROKE; THICKNESS; TREATMENT INDICATION; TUNICA MEDIA;

AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAROTID ARTERY, COMMON; COGNITION DISORDERS; DEMENTIA; HUMANS; TUNICA INTIMA; TUNICA MEDIA;

EID: 4444306379     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2004.05.012     Document Type: Editorial

References (35)

1. Hachinski V.C., Lassen N.A., Marshall J. Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet. 2(7874):1974;207-210
2. Wu C., Zhou D., Wen C., Zhang L., Como P., Qiao Y. Relationship between blood pressure and Alzheimer's disease in Linxian County, China. Life Sci. 72(10):2003;1125-1133
3. Skoog I., Lernfelt B., Landahl S., Palmertz B., Andreasson L.A., Nilsson L., et al. 15-year longitudinal study of blood pressure and dementia [see comments]. Lancet. 347(9009):1996;1141-1145
4. Ivan C.S., Seshadri S., Beiser A., Au R., Kase C.S., Kelly-Hayes M., et al. Dementia after stroke: the Framingham study. Stroke. 35(6):2004;1264-1268
5. Honig L.S., Tang M.X., Albert S., Costa R., Luchsinger J., Manly J., et al. Stroke and the risk of Alzheimer disease. Arch. Neurol. 60(12):2003;1707- 1712
6. Snowdon D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., Markesbery W.R. Brain infarction and the clinical expression of Alzheimer disease. The nun study. JAMA. 277(10):1997;813-817
7. Forette F., Seux M.-L., Staessen J., Thij L., et al. Prevention of dementia in the Syst-Eur trial. Lancet. 352:1998;1347-1351
8. Mogi N., Umegaki H., Hattori A., Maeda N., Miura H., Kuzuya M., et al. Cognitive function in Japanese elderly with type 2 diabetes mellitus. J. Diabetes Complications. 18(1):2004;42-46
9. Logroscino G., Kang J.H., Grodstein F. Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years. BMJ. 328(7439):2004;548
10. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino R.B., et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346(7):2002;476-483
11. McIlroy S.P., Dynan K.B., Lawson J.T., Patterson C.C., Passmore A.P. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke. 33(10):2002;2351-2356
12. Zamrini E., McGwin G., Roseman J.M. Association between statin use and Alzheimer's disease. Neuroepidemiology. 23(1-2):2004;94-98
13. Amarenco P., Lavallee P., Touboul P.J. Statins and stroke prevention. Cerebrovasc. Dis. 17(Suppl 1):2004;81-88
14. Amarenco P., Bogousslavsky J., Callahan A.S., Goldstein L., Hennerici M., Sillsen H., et al. Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study. Cerebrovasc. Dis. 16(4):2003;389-395
15. Talleli P, Ellul J, Terzis G, Lekka NP, Gioldasis G, Chrysanthopoulou A, et al. Common carotid artery intima media thickness and post stroke cognitive impairment. J Neurol Sci. doi=10.1016/j.jns.2004.05.013.
16. Spence J.D., Hegele R.A. Noninvasive phenotypes of atherosclerosis: similar windows but different views. Stroke. 35:2004;649-653
17. Spence J.D. Advances in Atherosclerosis: new understanding based on endothelial function. Fisher M., Bogousslavsky J. Current review of cerebrovascular disease. 1999;1-13 Current Medicine, Philadelphia
18. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., Wolfson S.K., et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N. Engl. J. Med. 340:1999;14-22
19. Hegele R.A., Ban M.R., Anderson C.M., Spence J.D. Infection- susceptibility alleles of mannose-binding lectin are associated with increased carotid plaque area. J. Invest. Med. 48:2003;198-202
20. Spence J.D., Barnett P.A., Hegele R.A., Marian A.J., Freeman D., Malinow M.R. Plasma Homocyst(e)ine, but not MTHFR genotype, is associated with variation in carotid plaque area. Stroke. 30:1999;969-973
21. Spence J.D., Barnett P.A., Bulman D.E., Hegele R.A. An approach to ascertain probands with a non traditional risk factor for carotid atherosclerosis. Atherosclerosis. 144:1999;429-434
22. Spence J.D., Ban M.R., Hegele R.A. Lipoprotein lipase (LPL) gene variation and progression of carotid artery plaque. Stroke. 34:2003;1178-1182
23. Kannel W.B., Cobb J. Left ventricular hypertrophy and mortality-results from the Framingham study. Cardiology. 81(4-5):1992;291-298
24. Spence J.D., Eliasziw M., DiCicco M., Hackam D.G., Galir R., Lohmann T. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke. 33:2002;2916-2922
25. Ebrahim S., Papacosta O., Whincup P., Wannamethee G., Walker M., Nicolaides A.N., et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British regional heart study. Stroke. 30(4):1999;841-850
26. Aminbakhsh A., Frohlich J., Mancini G.B. Detection of early atherosclerosis with B mode carotid ultrasonography: assessment of a new quantitative approach. Clin. Invest. Med. 22(6):1999;265-274
27. Spence J.D. Cerebral consequences of hypertension. Laragh J.H., Brenner B. Hypertension: pathophysiology, diagnosis, and management. 1995;741-753 Raven Press, New York
28. Lindholm L.H., Ibsen H., Dahlof B., Devereux R.B., Beevers G., de Faire U., et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 359(9311):2002;1004-1010
29. Lithell H., Hansson L., Skoog I., Elmfeldt D., Hofman A., Olofsson B., et al. The study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention trial. J. Hypertens. 21(5):2003;875-886
30. Tzourio C., Anderson C., Chapman N., Woodward M., Neal B., MacMahon S., et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch. Intern. Med. 163(9):2003;1069-1075
31. Bosch J., Yusuf S., Pogue J., Sleight P., Lonn E., Rangoonwala B., et al. Use of ramipril in preventing stroke: double blind randomised trial. BMJ. 324(7339):2002;699-702
32. Fogari R., Mugellini A., Zoppi A., Marasi G., Pasotti C., Poletti L., et al. Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension. Eur. J. Clin. Pharmacol. 59(12):2004;863-868
33. Ainsworth C.D., Spence J.D., Landry A.M., Blake C.C., Tamayo A., Fenster A. 3-D ultrasound carotid plaque volume: a tool for quickly measuring effects of treatment on atherosclerosis. Stroke. 35(247):2004
34. Landry A.M., Spence J.D., Fenster A. Measurement of carotid plaque volume by 3-dimensional ultrasound. Stroke. 35:2004;864-869
35. Spence J.D., Hegele R.A. Non-invasive assessment of atherosclerosis risk. Curr. Drug Targets-Cardiovasc. Haematol. Disord. 4:2004;125-128